淳中科技(603516.SH):與N公司對接的業務均為定製開發產品
格隆匯7月29日丨淳中科技(603516.SH)在投資者互動平台表示,公司積極開拓海外業務並取得突破性進展,與國際知名圖形技術和人工智能計算領域的領導者N公司建立了業務合作關係,公司已經取得了N公司的Vendor Code,有資格向N公司直接供貨,並可持續拓展新業務。公司與N公司對接的業務主要是各類產品的測試與檢測平台,目前正在對接的產品包括:液冷測試平台、基於AI的檢測平台、各種測試板卡等。公司與N公司對接的業務均為定製開發產品,需要取得Vendor Code並充分了解客户需求後才能完成相應的方案設計和產品規劃等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.